CAS: 56961-78-5; 2,4-Dichloro-5-Picoline

相似化合物

132097-09-7 1196146-42-5 73998-96-6

上下游产品

2-chloro-5-methylpyridine-N-oxide 2-chloro-5-methylpyridine 2,6-dichloro-3-methyl-5-nitropyridine 2-chloro-4-methoxy-5-methylpyridine

2-氯-5-甲基吡啶-N-氧化物置于三乙胺,三氯氧磷体系中,用 二氯甲烷 作为反应溶剂,化学反应 3.58H,反应生成 2,6-二氯-3-甲基吡啶,2,4-二氯-5-甲基吡啶
参考文献: Imidazopyridine Compound[fr] Composé Imidazopyridine
标题: Imidazopyridine Compound[fr] Composé Imidazopyridine
摘要:由以下一般式(1)表示的化合物,或其盐或水合物:其中r1代表可被取代的c1-C6烷基或c2-C6炔基,或可被取代的苯基,R2代表氢原子或c1-C6烷基,R3代表甲基或乙基基团,R4代表c1-C6烷基,R5代表氢原子,但其中r1为未取代或取代为卤素原子的c1-C6烷基,且r2为氢原子的化合物除外.

专利信息

专利号:WO-2016187028-A1
优先权日:2015-05-15
标 题 :Heteroaryl compounds, synthesis thereof, and intermediates thereto
发明人：FERNANDEZ PAUL FRANK; FERRETTI ANTONIO CHRISTIAN; HAN JIANXIN; TRAVERSE JOHN; TUNG HSIEN-HSIN; YONG KELVIN HIN-YEONG; ZOU NANFEI
权利人:CELGENE AVILOMICS RES INC
摘要:The present invention relates to methods for synthesizing compounds useful as inhibitors or both of ERK1 and ERK2 kinase, derivatives thereof, and intermediates thereto.

专利号:US-11459325-B2
优先权日:2018-01-31
标题:Heterocyclic compound
发明人：TANAKA YUTA; OHASHI TOMOHIRO; IKEDA ZENICHI; TANAKA YUTA; PÃœNNER FLORIAN; YAMAMOTO TAKESHI; KAKEGAWA KEIKO; KIKUCHI FUMIAKI; MORISHITA NAO; KASAHARA TAKAHITO; SETO MASAKI; NAKAMURA MINORU; TAKAMI KAZUAKI; MURAKAMI MASATAKA; DAINI MASAKI; MIKAMI SATOSHI; SASAKI MINORU
权利人:TAKEDA PHARMACEUTICALS CO
摘要:The present invention provides a compound having a glucosylceramide lowering action (e.g., promoting glucosylceramide metabolism, inhibition of glucosylceramide synthesis, promoting glucosylceramide catabolism, etc.), which is expected to be useful as an agent for the prophylaxis or treatment of lysosome diseases (e.g., Gaucher's disease), neurodegenerative diseases (e.g., Parkinson's disease, Lewy body dementia, multiple-system atrophy) and the like. n The present invention relates to a compound represented by the formula (I): n nwherein each symbol is as described in the specification, or a salt thereof.